Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 123 participants.

Also called NCT06576427

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 123 participants (enrolled count) (from the registry)
Sponsor
Jupiter Endovascular (from the registry)
Registry
  • NCT NCT06576427
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Austria, Poland, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06576427. Allocation not applicable; no masking; primary purpose treatment. Start 2024-10-15 (actual); primary completion 2026-02-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II
Acronym
SPIRARE II
Intervention (Device)
Vertex Pulmonary Embolectomy System
Lead sponsor
Jupiter Endovascular (class: industry)

Record details

Record id
cardio:ct-nct06576427
Content hash
c6247c04f170ca2ea7c5a8d7388f0d6d5877b30da00a384d480d2857312948d2